1080TiP An investigator-initiated phase I study to assess the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte (TIL) therapy in advanced immune checkpoint blockade (ICB) resistant solid tumors (NEXTGENTIL-ACT)
Saved in:
| Title: | 1080TiP An investigator-initiated phase I study to assess the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte (TIL) therapy in advanced immune checkpoint blockade (ICB) resistant solid tumors (NEXTGENTIL-ACT) |
|---|---|
| Authors: | Galvao, V.1 (AUTHOR), Palomero, J.2 (AUTHOR), Creus-Gonzalez, I.2 (AUTHOR), Lostes Bardaji, M.J.3 (AUTHOR), Lozano-Rabella, M.4 (AUTHOR), Garcia-Garijo, A.2 (AUTHOR), Yuste, A.4 (AUTHOR), Rodriguez, L.5 (AUTHOR), Villalobos Alberú, X.6 (AUTHOR), Rotxes, M.7 (AUTHOR), Vieito Villar, M.8 (AUTHOR), Saavedra Santa Gadea, O.3 (AUTHOR), Alonso, G.9 (AUTHOR), Braña, I.3 (AUTHOR), Muñoz-Couselo, E.10 (AUTHOR), Querol, S.5 (AUTHOR), Tabernero, J.11 (AUTHOR), Martín-Lluesma, S.12 (AUTHOR), Gros, A.13 (AUTHOR), Garralda, E.9 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS650-S650. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173099557 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1080TiP An investigator-initiated phase I study to assess the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte (TIL) therapy in advanced immune checkpoint blockade (ICB) resistant solid tumors (NEXTGENTIL-ACT) – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Galvao%2C+V%2E%22">Galvao, V.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Palomero%2C+J%2E%22">Palomero, J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Creus-Gonzalez%2C+I%2E%22">Creus-Gonzalez, I.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lostes+Bardaji%2C+M%2EJ%2E%22">Lostes Bardaji, M.J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lozano-Rabella%2C+M%2E%22">Lozano-Rabella, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garcia-Garijo%2C+A%2E%22">Garcia-Garijo, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yuste%2C+A%2E%22">Yuste, A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rodriguez%2C+L%2E%22">Rodriguez, L.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Villalobos+Alberú%2C+X%2E%22">Villalobos Alberú, X.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rotxes%2C+M%2E%22">Rotxes, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vieito+Villar%2C+M%2E%22">Vieito Villar, M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saavedra+Santa+Gadea%2C+O%2E%22">Saavedra Santa Gadea, O.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alonso%2C+G%2E%22">Alonso, G.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Braña%2C+I%2E%22">Braña, I.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Muñoz-Couselo%2C+E%2E%22">Muñoz-Couselo, E.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Querol%2C+S%2E%22">Querol, S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tabernero%2C+J%2E%22">Tabernero, J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martín-Lluesma%2C+S%2E%22">Martín-Lluesma, S.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gros%2C+A%2E%22">Gros, A.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garralda%2C+E%2E%22">Garralda, E.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS650-S650. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173099557 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.2977 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S650 Titles: – TitleFull: 1080TiP An investigator-initiated phase I study to assess the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte (TIL) therapy in advanced immune checkpoint blockade (ICB) resistant solid tumors (NEXTGENTIL-ACT) Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Galvao, V. – PersonEntity: Name: NameFull: Palomero, J. – PersonEntity: Name: NameFull: Creus-Gonzalez, I. – PersonEntity: Name: NameFull: Lostes Bardaji, M.J. – PersonEntity: Name: NameFull: Lozano-Rabella, M. – PersonEntity: Name: NameFull: Garcia-Garijo, A. – PersonEntity: Name: NameFull: Yuste, A. – PersonEntity: Name: NameFull: Rodriguez, L. – PersonEntity: Name: NameFull: Villalobos Alberú, X. – PersonEntity: Name: NameFull: Rotxes, M. – PersonEntity: Name: NameFull: Vieito Villar, M. – PersonEntity: Name: NameFull: Saavedra Santa Gadea, O. – PersonEntity: Name: NameFull: Alonso, G. – PersonEntity: Name: NameFull: Braña, I. – PersonEntity: Name: NameFull: Muñoz-Couselo, E. – PersonEntity: Name: NameFull: Querol, S. – PersonEntity: Name: NameFull: Tabernero, J. – PersonEntity: Name: NameFull: Martín-Lluesma, S. – PersonEntity: Name: NameFull: Gros, A. – PersonEntity: Name: NameFull: Garralda, E. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |